{"id":"W4365457148","doi":"10.1016/s1474-4422(23)00077-7","title":"Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study","year":2023,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":260,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network","funders":"UCB Pharma; National Institute of Neurological Disorders and Stroke","keywords":"Myasthenia gravis; Placebo; Medicine; Double blind; Phase (matter); Physical medicine and rehabilitation; Anesthesia; Physical therapy; Internal medicine; Alternative medicine; Physics; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007425659,0.0002801075,0.001424081,0.0002591713,0.00008963648,0.00001304841,0.0002160023,0.00009440642,0.00002950281],"category_scores_gemma":[0.00007796001,0.0001628558,0.00009654099,0.0004746697,0.0001840395,0.00004011144,0.0001156313,0.0004166675,0.00001192999],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001367771,"about_ca_system_score_gemma":0.0000537759,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000127283,"about_ca_topic_score_gemma":0.00008917006,"domain_scores_codex":[0.9977665,0.000433752,0.0005556261,0.0004476056,0.0003136803,0.0004828675],"domain_scores_gemma":[0.9984953,0.0004744359,0.0002429611,0.0005944486,0.00009177318,0.000101123],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9282078,0.001059409,0.06671634,0.00001646474,0.0003038778,0.0001389973,0.001554516,0.0001554324,0.00008824626,0.0002375221,0.0000698507,0.001451578],"study_design_scores_gemma":[0.7693163,0.006316104,0.2228283,0.00001912389,0.0002471069,0.00002217525,0.000070201,0.0008387885,0.00002741612,0.00005066278,0.0001395002,0.0001243849],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931196,0.00006258392,0.00001129884,0.001293451,0.00009241523,0.00496592,0.00002341178,0.00006930789,0.0003620312],"genre_scores_gemma":[0.9990019,0.00003007553,0.00002004649,0.0004225863,0.0001386707,0.0002103325,0.00003302822,0.00004186392,0.0001015097],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1588915,"threshold_uncertainty_score":0.6641068,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03103543463197126,"score_gpt":0.2935092215555304,"score_spread":0.2624737869235592,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}